Laboratoires Thea

This study is testing whether an experimental drug called ultevursen, given as an injection into the eye, can slow the progression of vision loss in people with retinitis pigmentosa caused by specific mutations in the USH2A gene. The trial will enroll 81 participants, who will be…

This study is testing whether regular eye injections of an experimental drug called sepofarsen can improve vision in people with a specific genetic form of Leber congenital amaurosis (LCA), which causes severe vision loss from childhood. In this carefully designed trial, each par…

This study is testing a new, preservative-free eye drop formula to see if it can relieve the symptoms of dry eye disease and improve patients' quality of life. Thirty adults with dry eye will use the drops daily for six months and report on their symptoms. The main goal is to see…

This study aims to understand how consistently people with glaucoma use their prescribed eye drop medication in daily life. It will follow 200 adult patients in Italy who already use a specific type of eye drop bottle. Researchers will use a small connected device that clips onto…